Market Cap
$106.7M
VXRT
Vaxart, Inc.
$0.4400 ▲ +0.00%
Prev close $0.4400Market cap$106.7M
12-mo target$3.33 (+657.6%)
High Impact Filing (7/10) Biotech & Drug Discovery
Snapshot
The big-picture read on VXRT right now — valuation, ownership and activity at a glance.
Cap Size
Micro Cap
Inst. Holders
1 funds
Inst. Value
$24.00
Inst. Activity
1 buys / 0 sells
Insider Activity
$6.5K buy / $0.00 sell
Insider Net $
$6.5K
Social Sentiment
50° Neutral
SEC Reports
19
Press Releases
2
Price chart 30d -10.2%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Aug 6, 2026 earnings_calendar
Jul 28, 2026 SEC VXRT Q2 2026 Earnings Scheduled — 2026-08-06
Vaxart filed an 8-K reporting a routine reorganization of its Board committees, appointing Kevin P. Finney as chair of t
8-K — Impact 2/10
Jul 16, 2026 Insider
HERON ELAINE J was granted 78,700 shares
Director
Jul 16, 2026 Insider
BREITMEYER JAMES B was granted 8,315 shares
Director
Jul 16, 2026 Insider
Jul 7, 2026 SEC HERON ELAINE J was granted 39,400 shares
Director
Vaxart reported topline 12-month safety data from the 400-participant sentinel safety cohort of its Phase 2b oral pill C
8-K — Impact 4/10
Vaxart and the Houle Stockholder Group entered into a Cooperation Agreement on July 1, 2026, ending the proxy contest fo
DEFA14A — Impact 5/10
Vaxart announced a $25 million at-the-market equity financing facility with Lincoln Park Capital, allowing the company t
Impact 4/10
Analyst ratings buy % +0.0%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Mar 27, 2025 | B. Riley Securities | MAINTAIN | Buy | 54% |
| Aug 15, 2024 | Oppenheimer | INITIATE | Outperform | 52% |
| Jan 31, 2024 | B. Riley Securities | UPGRADE | Buy | 54% |
| Sep 7, 2023 | Cantor Fitzgerald | REITERATE | Overweight | 49% |
| Aug 7, 2023 | Cantor Fitzgerald | MAINTAIN | Overweight | 49% |
| Dec 19, 2022 | B. Riley Securities | MAINTAIN | Neutral | 54% |
| Sep 2, 2022 | Cantor Fitzgerald | MAINTAIN | Overweight | 49% |
| May 19, 2022 | B. Riley Securities | MAINTAIN | Neutral | 54% |
| Nov 2, 2021 | Cantor Fitzgerald | INITIATE | Overweight | 49% |
| Jun 30, 2021 | B. Riley Securities | DOWNGRADE | Neutral | 54% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 4 | 4 | 1 | 0 | 0 | 89% | |
| Aug 1, 2026 | 4 | 4 | 1 | 0 | 0 | 89% | |
| Jul 1, 2026 | 3 | 4 | 1 | 0 | 0 | 88% | |
| Jun 1, 2026 | 3 | 4 | 1 | 0 | 0 | 88% | |
| May 1, 2026 | 4 | 4 | 1 | 0 | 0 | 89% | |
| Apr 1, 2026 | 4 | 4 | 1 | 0 | 0 | 89% | |
| Mar 1, 2026 | 4 | 4 | 1 | 0 | 0 | 89% | |
| Feb 1, 2026 | 4 | 4 | 1 | 0 | 0 | 89% |
Price targets
Where 3 covering analysts think VXRT trades over the next 12 months.
$3.33 +657.6% upside Strong Buy
Current$0.4400 Low$2.00 Median$4.00 High$4.00 3 analysts
$2.00$4.00
Analyst rating None as of Oct 2, 2026
Social media sentiment mood +0.0%
Retail-investor mood aggregated across social media. 0° = very bearish, 100° = very bullish.
50°
Neutral
BearishNeutralBullish
Recent posts
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
19 SEC filing reports analyzed · 1 bullish, 2 bearish, 2 mixed, 14 neutral · avg impact 4.3/10.Plus 2 press releases.
NEUTRAL8-K2/10
Vaxart filed an 8-K reporting a routine reorganization of its Board committees, appointing Kevin P.
Jul 28, 2026
NEUTRAL8-K4/10
Vaxart reported topline 12-month safety data from the 400-participant sentinel safety cohort of its
Jul 7, 2026
NEUTRALDEFA14A5/10
Vaxart and the Houle Stockholder Group entered into a Cooperation Agreement on July 1, 2026, ending
Jul 6, 2026
BULLISHDEFA14A5/10
Vaxart has reached an agreement with a group of shareholders to resolve its ongoing proxy contest, a
Jul 2, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Aug 6, 2026
earnings_calendar
VXRT Q2 2026 Earnings Scheduled — 2026-08-06
Jul 30, 2026
earnings_calendar
VXRT Q2 2026 Earnings Scheduled — 2026-07-30
May 7, 2026
earnings_calendar
VXRT Q1 2026 Earnings Scheduled — 2026-05-07
May 6, 2026
earnings_calendar
VXRT Q1 2026 Earnings Scheduled — 2026-05-06
May 1, 2026
earnings
Vaxart to Host Stockholder Fireside Chat on May 8 at 4:30 p.m. ET
Company to report first quarter 2026 financial results on May 7
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $-0.31 | $-0.31–$-0.31 | -675.0% | — | — | $0.0B | 1 |
| Next Q | $-0.19 | $-0.19–$-0.19 | -179.2% | — | — | $0.0B | 1 |
| Current FY | $-0.68 | $-0.68–$-0.68 | -1071.4% | -1233.3% | 0↑ 1↓ | $0.1B | 1 |
| Next FY | $-1.03 | $-1.03–$-1.03 | -51.5% | -51.5% | 0↑ 1↓ | $0.0B | 1 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $-0.310 | — |
| 7d ago | $0.000 | -0.310 |
| 30d ago | $0.000 | -0.310 |
| 60d ago | $0.000 | -0.310 |
| 90d ago | $0.000 | -0.310 |
Institutional ownership
Which big funds own VXRT (from quarterly 13F filings) and who is adding or trimming.
1 institutional holders with $24.00 total value (40 shares) as of 2026-Q1. Top holders: First.
Top holders — 2026-Q1
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| First Command Advisory Services, Inc. | 40 | $24.00 | 100.0% | — |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| SIMPLEX TRADING, LLC | ADD | 12,892 | 18,592 | +44.2% | $6.00 |
| UBS Group AG | ADD | 559,206 | 825,758 | +47.7% | $373.2K |
| Squarepoint Ops LLC | TRIM | 804,475 | 446,852 | -44.5% | $202.0K |
| ROYAL BANK OF CANADA | DOUBLED | 606 | 223,866 | +36841.6% | $101.0K |
| TWO SIGMA INVESTMENTS, LP | DOUBLED | 13,824 | 106,929 | +673.5% | $48.3K |
| GOLDMAN SACHS GROUP INC | ADD | 76,156 | 97,407 | +27.9% | $44.0K |
| Corient Private Wealth LLC | DOUBLED | 19,825 | 39,650 | +100.0% | $17.9K |
| Sequoia Financial Advisors, LLC | TRIM | 63,613 | 37,000 | -41.8% | $16.7K |
| HighTower Advisors, LLC | TRIM | 29,051 | 17,051 | -41.3% | $7.7K |
| MILLENNIUM MANAGEMENT LLC | NEAR_EXIT | 955,866 | 12,341 | -98.7% | $5.6K |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
10 insiders, 37 transactions. Net $6.5K — $6.5K bought, $0.00 sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 16, 2026 | HERON ELAINE J | Director | AWARD | 78,700 | — | — |
| Jul 16, 2026 | BREITMEYER JAMES B | Director | AWARD | 8,315 | — | — |
| Jul 16, 2026 | HERON ELAINE J | Director | AWARD | 39,400 | — | — |
| Jul 16, 2026 | Wheadon David E. | Director | AWARD | 39,400 | — | — |
| Jul 16, 2026 | Watson W. Mark | Director | AWARD | 78,700 | — | — |
| Jul 16, 2026 | Watson W. Mark | Director | AWARD | 39,400 | — | — |
| Jul 16, 2026 | Wheadon David E. | Director | AWARD | 78,700 | — | — |
| Jul 16, 2026 | BREITMEYER JAMES B | Director | AWARD | 16,610 | — | — |
| Jul 16, 2026 | Finney Kevin | Director | AWARD | 39,400 | — | — |
| Jul 16, 2026 | Finney Kevin | Director | AWARD | 78,700 | — | — |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for VXRT.
Shares short
2,306,655
Settlement Sep 15, 2026
Change vs prior
-0.2%
Semi-monthly cycle
Days to cover
4.5
At avg daily volume
All VXRT filing & press-release reports (21)
- 8-K reportJul 28, 2026
- 8-K reportJul 7, 2026
- DEFA14A reportJul 6, 2026
- DEFA14A reportJul 2, 2026
- 8-K reportJul 2, 2026
- 8-K reportJun 26, 2026
- DEFA14A reportJun 26, 2026
- DEFA14A reportJun 26, 2026
- DEFA14A reportJun 16, 2026
- DEFA14A reportJun 8, 2026
- DEFA14A reportJun 8, 2026
- DEFA14A reportJun 1, 2026
- DEFA14A reportMay 20, 2026
- DEFA14A reportMay 20, 2026
- PREC14A reportMay 19, 2026
- DEFA14A reportMay 19, 2026
- PRESS-RELEASE reportMay 1, 2026
- 8-K reportApr 21, 2026
- PRESS-RELEASE reportApr 17, 2026
- 8-K reportApr 17, 2026
- PRESS-RELEASE reportMar 3, 2026